During the past decade, AZ Delta (Campus Wilgenstraat) conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Delta (Campus Wilgenstraat)" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 1 trials sponsored and "Ottawa Heart Institute Research Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Delta (Campus Wilgenstraat)" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Biotronik Canada Inc" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AZ Delta (Campus Wilgenstraat)" are "Acute Myeloid Leukemia" (1 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Breast Cancer" (1 trials) and "Chronic Renal Anemia" (1 trials). Many other conditions were trialed in "AZ Delta (Campus Wilgenstraat)" in a lesser frequency.

Most popular intervention types in "AZ Delta (Campus Wilgenstraat)" are "Drug" (14 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "methoxy polyethylene glycol-epoetin beta" (2 trials), "33A" (1 trials), "Acetylsalicylic acid" (1 trials) and "Alectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "AZ Delta (Campus Wilgenstraat)" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AZ Delta (Campus Wilgenstraat)". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in AZ Delta (Campus Wilgenstraat), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Delta (Campus Wilgenstraat), 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".